/PRNewswire/ HanAll Biopharma (KRX: 009420.KS) announced today the appointment of Almira Chabi, M.D. as Chief Medical Officer and Chief Development Officer.
/PRNewswire/ HanAll Biopharma (KRX: 009420.KS) announced today the appointment of Almira Chabi, M.D. as Chief Medical Officer and Chief Development Officer.
HanAll Biopharma Appoints Almira Chabi as Chief Medical Officer and Chief Development Officer - read this article along with other careers information, tips and advice on BioSpace
We are in the midst of a moment where AI is under the microscope, with policymakers picking apart AI contributions and demanding that AI meet high standards of performance. However, I fear in the drive to make AI better, the perfect may become the enemy of the good.